The role of zofenopril in myocardial protection during cardioplegia arrest: An isolated rat heart model

Journal of Cardiac Surgery

Volumn 21, Issue 1, 2006, Pages 44-49

  Leva, Cristian ^a   Mariscalco, Giovanni ^a,b   Ferrarese, Sandro ^a   Bruno, Vito Domenico ^a   Orrù, Alessandro ^a   Cattaneo, Paolo ^a   Sala, Andrea ^a  

^a University of Varese   (Italy)

^b University Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE; ZOFENOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME RELEASE; HEART PROTECTION; MALE; NONHUMAN; PERFUSION; PROTEIN EXPRESSION; RAT; REPERFUSION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CREATINE KINASE; DISEASE MODELS, ANIMAL; HEART ARREST, INDUCED; INTRAOPERATIVE PERIOD; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; TREATMENT OUTCOME; VENTRICULAR PRESSURE;

EID: 33645226931     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2006.00167.x     Document Type: Article

References (34)

1. Di Pasquale P Paterna S Valenza M et al Effects of captopril on myocardial protection during cardioplegia Int J Cardiol 1993 42 225 230
2. Dogan R Sarigul A Isbir S et al Beneficial effect of captopril against ischaemia-reperfusion injury in isolated guinea pig hearts Scand J Clin Lab Invest 1998 58 119 126
3. Zhang X Xie YW Nasjletti A et al ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption Circulation 1997 95 176 182
4. Rett K Maerker E Renn W et al Perfusion-independent effect of bradykinin and fosinoprilate on glucose transport in Langendorff rat hearts Am J Cardiol 1997 80 143A 147A
5. Frascarelli S Ghelardoni S Ronca-Testoni S et al Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion J Cardiovasc Pharmacol 2004 43 294 299
6. Ambrosioni E Bacchelli S Esposti DD et al Anti-ischemic effects of angiotensin-converting enzyme inhibitors: A future therapeutic perspective J Cardiovasc Pharmacol 2001 37 Suppl 1 S3 S9
7. Ambrosioni E Borghi C Magnani B The effect of the angiotensin-converting- enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators N Engl J Med 1995 332 80 85
8. Borghi C Ambrosioni E Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study Am Heart J 2003 145 80 87
9. Ertl G Kloner RA Alexander RW et al Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor Circulation 1982 65 40 48
10. Hock CE Ribeiro LG Lefer AM Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction Am Heart J 1985 109 222 228
11. Lefer AM Peck RC Cardioprotective effects of enalapril in acute myocardial ischemia Pharmacology 1984 29 61 69
12. Daniell HB Carson RR Ballard KD et al Effects of captopril on limiting infarct size in conscious dogs J Cardiovasc Pharmacol 1984 6 1043 1047
13. de Lorgeril M Ovize M Delaye J et al Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction J Cardiovasc Pharmacol 1992 19 324 329
14. Zhu B Sun Y Sievers RE et al Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion J Am Coll Cardiol 2000 35 787 795
15. Lazar HL Bao Y Rivers S et al High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size Ann Thorac Surg 2001 72 548 553 discussion 553-544
16. Grover GJ Sleph PG Dzwonczyk S et al Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: Relationship between cardiac ACE inhibition and cardioprotection J Pharmacol Exp Ther 1991 257 919 929
17. Liu X Engelman RM Rousou JA et al Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors Cardiovasc Drugs Ther 1992 6 437 443
18. Linz W Scholkens BA Han YF Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts J Cardiovasc Pharmacol 1986 8 Suppl 10 S91 S99
19. Pfeffer MA Braunwald E Moye LA et al Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 1992 327 669 677
20. Dzau VJ Circulating versus local renin-angiotensin system in cardiovascular homeostasis Circulation 1988 77 I4 13
21. Tan LB Jalil JE Pick R et al Cardiac myocyte necrosis induced by angiotensin II Circ Res 1991 69 1185 1195
22. Martorana PA Kettenbach B Breipohl G et al Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist Eur J Pharmacol 1990 182 395 396
23. Noda K Sasaguri M Ideishi M et al Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs Cardiovasc Res 1993 27 334 340
24. Hartman JC Hullinger TG Wall TM et al Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition Eur J Pharmacol 1993 234 229 236
25. Matoba S Tatsumi T Keira N et al Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes Circulation 1999 99 817 822
26. Kitakaze M Node K Takashima S et al Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: Role of bradykinin and nitric oxide Hypertens Res 2000 23 253 259
27. Vivaldi MT Kloner RA Schoen FJ Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats Am J Pathol 1985 121 522 530
28. Schulz R Cohen MV Behrends M et al Signal transduction of ischemic preconditioning Cardiovasc Res 2001 52 181 198
29. Chopra M Beswick H Clapperton M et al Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: Free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors J Cardiovasc Pharmacol 1992 19 330 340
30. DeForrest JM Waldron TL Krapcho J et al Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme J Cardiovasc Pharmacol 1989 13 887 894
31. Ferrari R Cargnoni A Curello S et al Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: Insight into its mechanism of action J Cardiovasc Pharmacol 1992 20 694 704
32. Cominacini L Pasini A Garbin U et al Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species Am J Hypertens 2002 15 891 895
33. Randsbaek F Kimose HH Bjerre T et al Captopril-induced glutamate release at the start of reperfusion after cold cardioplegic storage of pig hearts J Thorac Cardiovasc Surg 2000 119 1030 1038
34. Gurevitch J Pevni D Frolkis I et al Captopril in cardioplegia and reperfusion: Protective effects on the ischemic heart Ann Thorac Surg 1997 63 627 633